Global Diabetes Monitors Market Analysis & Forecast 2017 To 2023


The global diabetes monitors market is expected to reach USD 17458.1 million by 2023 at a CAGR of 8.3%.

SKU: 180126 Category: Tags: ,


Diabetes is a chronic disease characterized by elevated levels of blood glucose which leads to serious damage to the heart, eyes, kidneys, blood vessels and nerves. The most common of diabetes is type 2 diabetes which occurs when the body becomes resistant to insulin or doesn’t make enough insulin. In the past three decades the prevalence of type 2 diabetes has risen dramatically in countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself.
The market of diabetes monitor is increasing due to an increase in the prevalence of diabetes, changing lifestyle and increasing use of insulin for the treatment of diabetes. Increase awareness regarding prevention and treatment of diabetes, and increasing demand for technologically advanced devices for diabetes monitoring.
The global diabetes monitors market is expected to reach USD 17458.1 million by 2023 at a CAGR of 8.3%.
The global diabetes monitors market is segmented on the basis of sample, type, component, and end-users. On the basis of sample, the market is segmented into blood samples, sweat samples, urine samples, and others. On the basis of type, the market is classified into point sample test based glucose monitors, continuous glucose monitors, and enzyme free sensor based glucose monitors. Continuous glucose monitors are further segmented into disposable sensor based CGM, and re-usable sensor based CGM. On the basis of components, the market is classified into lancet, glucose test strips, and sensors. Sensors are further segmented into enzyme-based sensors, and enzyme-free sensors
On the basis of end -users, the market is segmented into diagnostic clinics, hospitals, and home.
Key Players:
The leading players in the global diabetes monitor market are Panasonic, Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd , Medtronic, LifeScan, Inc., Sanofi, and others.
Study objectives of diabetes Monitor market:
 To provide insights about factors influencing and affecting the market growth
 To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets
 To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience:
• Medical devices manufacturers
• Medical devices distributors
• Hospitals & Clinics
• Potential investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings:
• On the basis of sample, blood sample market is expected to command the largest market share of 75.70% over the review period and it is also expected to grow at the fastest CAGR of 8.6% during the forecast period 2017-2023
• Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 8.9% over the 2017-2023
The reports also cover country level analysis:
• America
• North America
• US
• Canada
• Latin America
• Europe
• Western Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest Of Western Europe
• Eastern Europe
• Asia-Pacific
• Japan
• China
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
• Saudi Arabia
• Oman
• Kuwait
• Qatar
• Rest of Middle East & Africa

Table of Contents

1 Report Prologue
1.1 Introduction
2 Introduction
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.4.1 Trade Analysis
3.4.2 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence and incidence of diabetes mellitus (DM) (Impact Weightage-35%)
4.2.2 Rise in technological innovations (Impact Weightage-30%)
4.2.3 Research funding in diabetes diagnosis and treatment (Impact Weightage-15%)
4.2.4 Rising awareness and screening for Diabetes Mellitus (Impact Weightage-20%)
4.3 Restraints
4.3.1 Stringent reimbursement and insurance policies in developing nations, can hamper the market growth in coming future (Impact Weightage-35%)
4.3.2 High cost associated with diagnosis and treatment of diabetes (Impact Weightage-65%¬)
4.4 Opportunities
4.4.1 Technologically advanced products in the pipeline
4.4.2 Rise in Global Obesity Population
4.4.3 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Raw Material
5.2.2 Supplier
5.2.3 Manufacturer
5.2.4 Distributer
5.2.5 Customer
5.2.6 Consumer
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Diabetes Monitors Market by Sample
6.1 Introduction
6.2 Blood Samples
6.3 Sweat Samples
6.4 Urine Samples
6.5 Others
7 Global Diabetes Monitors Market by Type
7.1 Introduction
7.2 Point sample test based Glucose Monitors
7.3 Continuous glucose monitors
7.4 Enzyme free sensor based Glucose Monitors
8 Global Diabetes Monitors Market by Components
8.1 Introduction
8.2 Lancet
8.3 Glucose test strips
8.4 Sensors
9 Global Diabetes Monitors Market by End Users
9.1 Introduction
9.2 Diagnostic Clinics
9.3 Hospitals
9.4 Home
10 Global Diabetes Monitors Market by Regions
10.1 Introduction
10.2 Americas
10.2.1 US
10.2.2 Canada
10.2.3 South America
10.3 Europe
10.3.1 Western Europe Germany France Italy Spain UK Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 UAE
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of Middle East & Africa
11 Competitive Landscape
11.1 Introduction
12 Company Profiles
12.1 Panasonic
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products
12.1.4 Strategy
12.1.5 Key Developments
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products
12.2.4 Strategy
12.2.5 Key Developments
12.3 Dexcom, Inc.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products
12.3.4 Strategy
12.3.5 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products
12.4.4 Strategy
12.4.5 Key Developments
12.5 LifeScan, Inc.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products
12.5.4 Strategy
12.5.5 Key Developments
12.6 Sanofi
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products
12.6.4 Strategy
12.6.5 Key Developments
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.2 Key companies to watch
14 Appendix
14.1 Discussion Blue Print

Additional information


Geography Covered

Date Published